![David Englert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Englert
Directeur Technique/Scientifique/R&D chez Axela, Inc.
Postes actifs de David Englert
Sociétés | Poste | Début | Fin |
---|---|---|---|
Axela, Inc.
![]() Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | 30/08/2011 | - |
Historique de carrière de David Englert
Anciens postes connus de David Englert
Sociétés | Poste | Début | Fin |
---|---|---|---|
Pharmacia LKB Biotechnology, Inc. | Corporate Officer/Principal | - | - |
Formation de David Englert
The State University of New York | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Canada | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Axela, Inc.
![]() Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
Pharmacia LKB Biotechnology, Inc. |
- Bourse
- Insiders
- David Englert
- Expérience